The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis

被引:3
作者
Kubiliute, Aleksandra [1 ]
Gedvilaite, Greta [2 ]
Vilkeviciute, Alvita [2 ]
Kriauciuniene, Loresa [2 ]
Bruzaite, Akvile [2 ]
Zaliuniene, Dalia [3 ]
Liutkeviciene, Rasa [2 ,3 ]
机构
[1] Lithuanian Univ Hlth Sci, Med Acad, Med Fac, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Neurosci Inst, Med Acad, Lab Ophthalmol, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Med Acad, Dept Ophthalmol, Eiveniu 2 Str, LT-50161 Kaunas, Lithuania
关键词
Optic neuritis; Multiple sclerosis; SIRT1; SNP; ELISA; NEUROPROTECTION; RESVERATROL; ACTIVATION; PROTECTS; DAMAGE; CELLS; MODEL;
D O I
10.1186/s13023-023-02665-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aimTo investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS).Methods79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0".ResultsWe discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development.ConclusionsSIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients
    Li, Rui
    Sun, Xiaobo
    Shu, Yaqing
    Wang, Yuge
    Xiao, Li
    Wang, Zhanhang
    Hu, Xueqiang
    Kermode, Allan G.
    Qiu, Wei
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 313 : 56 - 60
  • [22] Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: An Uncontrolled Clinical Trial
    Batoee, Shakiba
    Etminaniesfahani, Maryam
    Mazdeh, Mehrdokht
    Soltanian, Alireza
    Nouri, Fatemeh
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2023, 99
  • [23] SIRT1 gene polymorphisms are associated with growth traits in Nanyang cattle
    Li, Mingxun
    Sun, Xiaomei
    Hua, Liushuai
    Lai, Xinsheng
    Lan, Xianyong
    Lei, Chuzhao
    Zhang, Chunlei
    Qi, Xinglei
    Chen, Hong
    MOLECULAR AND CELLULAR PROBES, 2013, 27 (5-6) : 215 - 220
  • [24] Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes
    Emamgholipour, Solaleh
    Hossein-nezhad, Arash
    Sahraian, Mohammad Ali
    Askarisadr, Fatemeh
    Ansari, Mohammad
    LIFE SCIENCES, 2016, 145 : 34 - 41
  • [25] SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review
    Nimmagadda, Vamshi K. C.
    Makar, Tapas K.
    Chandrasekaran, Krish
    Sagi, Avinash Rao
    Ray, Jayanta
    Russell, James W.
    Bever, Christopher T., Jr.
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 304 : 29 - 34
  • [26] SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases
    Kilic, Ulkan
    Gok, Ozlem
    Bacaksiz, Ahmet
    Izmirli, Muzeyyen
    Elibol-Can, Birsen
    Uysal, Omer
    PLOS ONE, 2014, 9 (02):
  • [27] Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
    Zhu, Lin
    Yang, Miaomiao
    Fan, Lehao
    Yan, Qiuying
    Zhang, Lifeng
    Mu, Ping
    Lu, Fangjin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (01) : 89 - 101
  • [28] Sirt1: Role Under the Condition of Ischemia/Hypoxia
    Meng, Xiaofei
    Tan, Jin
    Li, Mengmeng
    Song, Shuling
    Miao, Yuyang
    Zhang, Qiang
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2017, 37 (01) : 17 - 28
  • [29] SIRT1 is regulated by a PPARγ-SIRT1 negative feedback loop associated with senescence
    Han, Limin
    Zhou, Rui
    Niu, Jing
    McNutt, Michael A.
    Wang, Pan
    Tong, Tanjun
    NUCLEIC ACIDS RESEARCH, 2010, 38 (21) : 7458 - 7471
  • [30] Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
    Knight, John R. P.
    Allison, Simon J.
    Milner, Jo
    OPEN BIOLOGY, 2013, 3 (11)